ArticleEnvironmental and molecular mutagenesis2025
Aflatoxin B
Irina G Minko, Vladimir L Vartanian, Michael M Luzadder, Yingming Wang, Lev M Fedorov, Amanda K McCullough, R Stephen Lloyd
Abstract read
In one paragraphArticle in Environmental and molecular mutagenesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Irina G MinkoOregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, Oregon, USA.
Vladimir L VartanianOregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, Oregon, USA.
Michael M LuzadderOregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, Oregon, USA.
Yingming WangTransgenic Mouse Models Shared Resource, Oregon Health and Science University, Portland, Oregon, USA.
Lev M FedorovTransgenic Mouse Models Shared Resource, Oregon Health and Science University, Portland, Oregon, USA.
Amanda K McCulloughOregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, Oregon, USA.
R Stephen LloydOregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, Oregon, USA.
Funding
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5MRole of Base Excision Repair in Limiting Hepatocellular Carcinomas -Administrative SupplementR01ES031086 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LLOYD, R. STEPHEN · 2020 to 2024
$2.0MThe roles of BER and TLS in limiting aflatoxin-induced carcinogenesisR56ES027632 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LLOYD, R. STEPHEN · 2017 to 2017
$308kDivision of Consumer and Business Services of the State of Oregon ORS 656.630Katherine Bisbee II Fund, Oregon Community FoundationNCI NIH HHS P30 CA069533NIEHS NIH HHS R01 ES031086NIEHS NIH HHS R56 ES027632NIH HHS ES-031086
6 · The paper itselfAbstract
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-associated mortality, correlating with obesity, alcohol consumption, hepatitis B and C infections, and dietary exposure to aflatoxin B
Indexed as
Aflatoxin B1Carcinoma, HepatocellularDNA GlycosylasesLiverLiver NeoplasmsMutagenesisAnimalsGene EditingMiceAflatoxin B1DNA GlycosylasesNeil1 protein, mouseDNA damageduplex sequencingFapy adductshepatocellular carcinomapolymorphic variant
Identifiers
PMID40342069
PMCPMC12088889
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390